LiBin Ma, MD, PhD

Dr. LiBin Ma is a senior medical director in Labcorp’s global medical affairs division. In his current role, LiBin provides medical consultation for Labcorp Central Laboratory Services as well as leadership for global medical affairs division. Prior to this, he was senior director of medical affairs and science for the Asia-Pacific region, responsible for the strategic and operational activities for medical affairs in the region. He also served as senior director for laboratory operations and science for the Asia-Pacific region, responsible for regional laboratory operations in Singapore, China and Japan.

Prior to joining Labcorp, LiBin was senior research scientist and group leader for cancer biomarkers with Eli Lilly and Company at the Lilly Singapore Centre for Drug Discovery and head of biology and laboratory head at Lilly Systems Biology. Before that, he was senior scientist at Crucell B.V. as well as at Galapagos B.V. in the Netherlands. He received his medical degree from Beijing Medical University (now Peking University Health Science Center) and his doctorate in molecular medicine from Leiden University (Netherlands).

LiBin is the CAP certificate holder for Labcorp Development (Asia) Pte Ltd. He is an international laboratory inspector trained and certified by CAP. LiBin sees medical affairs activities beyond compliance and gate-keeping and as part of scientific innovation and operational excellence. He is passionate about the application of biomarkers and genomics in companion diagnostics, precision medicine and clinical trials.